share_log

HC Wainwright & Co. Maintains Buy on Puma Biotechnology, Lowers Price Target to $7

Moomoo 24/7 ·  Mar 1 14:53

HC Wainwright & Co. analyst Edward White maintains Puma Biotechnology (NASDAQ:PBYI) with a Buy and lowers the price target from $8 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment